MAPT and supranuclear palsy, progressive, 1: As a proof‐of‐concept study to determine proximal or interacting proteins to p‐Tau in tissue pathology, we applied the BAR method and MS for unbiased, in situ identification of pathological p‐Tau aggregates and co‐aggregating protein partners in a small subset of PSP patient tissue.